Some ASMs can affect the development of a baby during pregnancy. This might be a factor in deciding which ASM is right for women and girls, even at a young age.
The Medicines and Healthcare products Regulatory Agency (MHRA) published the review, alongside a patient leaflet, to help individuals and healthcare professionals understand the evidence available.
Women and girls with epilepsy should have their medication regularly reviewed by their epilepsy specialist.
